Lineage Cell Therapeutics (LCTX) Deferred Taxes (2013 - 2023)
Lineage Cell Therapeutics (LCTX) reported Deferred Taxes of -$3000.0 for Q2 2023, up 99.83% quarter-over-quarter from -$1.8 million in Q1 2023.
Lineage Cell Therapeutics (LCTX) Deferred Taxes (2013 - 2023) Analysis & Trends
Lineage Cell Therapeutics has reported Deferred Taxes for 8 years, with the latest figure at -$3000.0 in Q2 2023.
- For the quarter ending Q2 2023, Deferred Taxes changed N/A year-over-year to -$3000.0; the trailing twelve-month figure through Mar 2024 stood at -$3000.0 (up 99.93% YoY), and the FY2025 full-year result was -$5.3 million, changed N/A from the prior year.
- Deferred Taxes for Q2 2023 stood at -$3000.0, up from -$1.8 million in the prior quarter.
- The five-year high for Deferred Taxes was -$3000.0 in Q2 2023, with the low at -$4.4 million in Q1 2019.
- Historically, Deferred Taxes has averaged -$1.2 million across 4 years, with a median of -$1.0 million in 2021.
- Annual changes were most pronounced in 2020 — Deferred Taxes jumped 79.82% — and 2021, when it sank 406.0%.
- Lineage Cell Therapeutics' Deferred Taxes stood at -$991000.0 in 2019, then slipped by 4.84% to -$1.0 million in 2020, then increased by 2.6% to -$1.0 million in 2021, then soared by 99.7% to -$3000.0 in 2023.
- The last three Deferred Taxes figures came in at -$3000.0 (Q2 2023), -$1.8 million (Q1 2023), and -$1.0 million (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | -1.80 Mn |
| Sep 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | -169,000.00 |
| Dec 31, 2020 | -1.04 Mn |
| Sep 30, 2020 | -200,000.00 |
| Sep 30, 2019 | -991,000.00 |
| Jun 30, 2019 | -1.25 Mn |
| Mar 31, 2019 | -4.38 Mn |
| Sep 30, 2017 | 4.77 Mn |
| Mar 31, 2017 | 3.88 Mn |
| Dec 31, 2015 | -1.12 Mn |
| Sep 30, 2015 | -948,000.00 |
| Jun 30, 2015 | -1.27 Mn |
| Mar 31, 2015 | -1.18 Mn |
| Dec 31, 2014 | -2.20 Mn |
| Sep 30, 2014 | -2.31 Mn |
| Jun 30, 2014 | -1.51 Mn |
| Mar 31, 2014 | -1.35 Mn |
| Dec 31, 2013 | -3.28 Mn |